APC
IONS icon

Aspire Private Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Aspire Private Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8
Closed – – 670
2022
Q3 		$0 Hold
8
– – ﹤0.01% 639
2022
Q2 		$0 Hold
8
– – ﹤0.01% 624
2022
Q1 		$0 Hold
8
– – ﹤0.01% 636
2021
Q4 		$0 Hold
8
– – ﹤0.01% 656
2021
Q3 		$0 Hold
8
– – ﹤0.01% 622
2021
Q2 		$0 Hold
8
– – ﹤0.01% 608
2021
Q1 		$0 Hold
8
– – ﹤0.01% 571
2020
Q4 		$0 Hold
8
– – ﹤0.01% 492
2020
Q3 		$0 Buy
+8
New +$444 ﹤0.01% 485
2020
Q1 		– Sell
-8
Closed – – 363
2019
Q4 		$0 Hold
8
– – ﹤0.01% 513
2019
Q3 		$0 Hold
8
– – ﹤0.01% 503
2019
Q2 		$1K Hold
8
– – ﹤0.01% 449
2019
Q1 		$1K Hold
8
– – ﹤0.01% 500
2018
Q4 		$0 Buy
+8
New +$408 ﹤0.01% 548

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Aspire Private Capital's IONS Position: Q4 2022 in Review

Aspire Private Capital sold out of Ionis Pharmaceuticals (IONS) in Q4 2022, closing a stake of 8 shares.

Aspire Private Capital first reported a position in IONS in Q4 2018 and held it in 14 quarters. The position peaked at $1K in Q2 2019. 338 funds tracked by Wall St. Rank hold IONS as of Q4 2022.

  • Aspire Private Capital reported no remaining Ionis Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Aspire Private Capital sold 8 Ionis Pharmaceuticals shares in Q4 2022.
  • Aspire Private Capital first reported a position in Ionis Pharmaceuticals in Q4 2018 and held it in 14 quarters.
  • Aspire Private Capital's Ionis Pharmaceuticals position peaked at $1K in Q2 2019.
  • 338 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2022.

Based on Aspire Private Capital's 13F filing for Q4 2022, filed 14 Feb 2023.